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Intima-media thicknessThe relationship between plasma triglyceride level and common
carotid artery intima-thickness (CCA-IMT) is strongly debated and
the available data have not yet conﬁrmed an unequivocal rela-
tionship [1]. In this issue of Atherosclerosis, Batluk et al. reports an
association between CCA-IMT and fasting triglyceride levels, but
not the post-challenge one with a standardized combined oral
glucose and fat tolerance test performed 3e7 days after ﬁrst ever
ischemic stroke. The glucose load was a standard oral glucose
tolerance test (OGTT), in this case associated to a lipid charge (i.e.
250 mL cream, ingested within 30 min), with measurement of
triglycerides level 3, 4 and 5 h post-challenge. Slow triglyceride
metabolizers were deﬁned as patients whose triglyceride levels
rose until 5 h post-challenge, while fast triglycerides metabolizers
as patients whose triglyceride values that rose sharply from 0 to
3 h post-challenge and thereafter declined. For all metabolism
categories (fast, medium, and slow), a rise in triglyceride levels was
deﬁned as a >10% increase in triglyceride values from one
consecutive time-point to the next (e.g. fasting to 3 h post-chal-
lenge; 3 he4 h post-challenge, and 4e5 h post-challenge) [2].
From a pathophysiological point of view, both fat and sugar
intake determines a dose-related increase in serum triglycerides
and, at the same time, a series of vascular effect ﬁnally leading toDOI of original article: http://dx.doi.org/10.1016/j.atherosclerosis.2015.09.003.
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0021-9150/© 2014 Published by Elsevier Ireland Ltd.intima-media thickening. The OGTT has been used largely as model
of post-prandial state [3]. Whenmimicing a condition of high sugar
intake with an OGTT, we could in fact observe an increase in lab-
oratory biomarkers of vascular inﬂammation and endothelial
dysfunction such as soluble intercellular adhesion molecule-1
(sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1),
interleukin-6 (IL-6), high-sensitivity C reactive protein (hsCRP), and
tumor necrosis factor-alpha (TNF-alpha) [4], and of parameters
related to vascular remodeling such as matrix metalloproteinases
(MMP) 9 [5], especially in diabetics who are usually hyper-
triglyceridemic. On the other hand, the use of drugs which can
reduce the increase of glycemia during an OGTT, such as acarbose
and pioglitazone, are associated with an improvement of almost all
the above cited laboratory parameters [6].
When considering the effect of an oral fat load (OFL) to mimic
post-prandial hypertriglyceridemia mainly related to the assump-
tion of dietary lipids, there is a linear trend between increasing
numbers of metabolic syndrome components and themagnitude of
the post-prandial triglycerides [7] and also an increase in labora-
torymarkers of vascular inﬂammation such as sICAM-1, IL-6, hsCRP,
sVCAM-1, Soluble E-selectin, and TNF-alpha [8], a decrease in bio-
markers of endothelial dysfunction such as nitrites/nitrates and
ADP and of parameters related to vascular remodeling such as
MMP-2 andMMP-9 [9]. Once again, the changes in the plasma level
of the most part of these parameters during an OFL are attenuated
by the use of drugs reducing the peak of triglycerides, such as
omega 3 polyunsaturated fatty acids [10] or acarbose [11].
So, from one side, it appears that the application of a stan-
dardized glucose and fat tolerance test could help to identify sub-
jects with higher post-prandial increase in plasma triglycerides
who could be target of a more intensive lipid-lowering treatment.
On the other side, it seems from the current study [2], that this test
is not able to detect subjects with more advanced vascular aging.
Before to ﬁnally exclude that the proposed test is able to detect
those patients potentially treatable with the drugs associated with
a greater modulation of post-prandial lipemia (polyunsaturated
fatty acids [12] and ﬁbrates [13]), it has to be remembered that
recent data have strongly reduced the relevance of carotid intima-
media thickness as a predictor of cardiovascular disease [14].
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vascular damage (as for instance ﬂow-mediated dilation or carotid-
femoral pulse wave velocity) are needed to evaluate the association
of vascular damage with higher level of post-prandial triglycerides
compared to other dyslipidaemic subjects, before to exclude the
usefulness of the proposed standardized combined oral glucose
and fat tolerance test.
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